Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Cortes, Jorge  [Clear All Filters]
2015
Oran, B., Jimenez, A.M., de Lima, M., Popat, U.R., Bassett, R., Andersson, B., Borthakur, G., Bashir, Q., Chen, J., Ciurea, S.O., et al. (2015). Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.Biol Blood Marrow Transplant.
Takahashi, K., Kantarjian, H., Garcia-Manero, G., Borthakur, G., Kadia, T., DiNardo, C., Jabbour, E., Pierce, S., Estrov, Z., Konopleva, M., et al. (2015). Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.Clin Lymphoma Myeloma Leuk.
Daver, N., Thomas, D., Ravandi, F., Cortes, J., Garris, R., Jabbour, E., Garcia-Manero, G., Borthakur, G., Kadia, T., Rytting, M., et al. (2015). Final report of a phase II study of imatinib mesylate with hyper-CVAD for the frontline treatment of adult patients with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia.Haematologica.
Han, L., Qiu, P., Zeng, Z., Jorgensen, J.L., Mak, D.H., Burks, J.K., Schober, W., McQueen, T.J., Cortes, J., Tanner, S.D., et al. (2015). Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.Cytometry A.
Carter, B.Z., Mak, P.Yee, Mak, D.H., Ruvolo, V.R., Schober, W., McQueen, T., Cortes, J., Kantarjian, H.M., Champlin, R.E., Konopleva, M., et al. (2015). Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells.Oncotarget.